TRACON Pharmaceuticals Inc
OTC:TCON

Watchlist Manager
TRACON Pharmaceuticals Inc Logo
TRACON Pharmaceuticals Inc
OTC:TCON
Watchlist
Price: 0.0322 USD
Market Cap: 109.8k USD

Wall Street
Price Targets

TCON Price Targets Summary
TRACON Pharmaceuticals Inc

There are no price targets for TCON.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
TRACON Pharmaceuticals Inc Competitors:
Price Targets
AUPH
Aurinia Pharmaceuticals Inc
8% Upside
ZEAL
Zealand Pharma A/S
61% Upside
FHTX
Foghorn Therapeutics Inc.
173% Upside
ZNTL
Zentalis Pharmaceuticals Inc
287% Upside
MDGL
Madrigal Pharmaceuticals Inc
3% Upside
NRIX
Nurix Therapeutics Inc
46% Upside
ONCO
Oncopeptides AB
6% Upside
TECX
AVROBIO Inc
343% Upside

Revenue
Forecast

Revenue Estimate
TRACON Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for TRACON Pharmaceuticals Inc's revenue is 5%. The projected CAGR for the next 3 years is 27%.

5%
Past Growth
27%
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Operating Income
Forecast

Operating Income Estimate
TRACON Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
TRACON Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TCON's stock price target?
Not Available

TCON doesn't have any price targets made by Wall Street professionals.

What is TRACON Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
27%

For the last 8 years the compound annual growth rate for TRACON Pharmaceuticals Inc's revenue is 5%. The projected CAGR for the next 3 years is 27%.

Back to Top